Cover Image
Read Now

Hematopoietic stem-cell transplantation in the pediatric population

OBJECTIVES: Assess comparative benefits and harms of hematopoietic stem-cell transplantation (HSCT) versus standard therapies or disease natural history in pediatric (age 21 years) patients with malignant solid tumors, inherited metabolic diseases, or autoimmune diseases. DATA SOURCES: MEDLINE(r), E...

Full description

Bibliographic Details
Main Author: Ratko, Thomas
Corporate Authors: Effective Health Care Program (U.S.), United States Agency for Health Care Policy and Research, Blue Cross and Blue Shield Association Technology Evaluation Center
Format: eBook
Language:English
Published: Rockville, MD Agency for Healthcare Research and Quality [2012], 2012
Series:Comparative effectiveness review
Subjects:
Neoplasms / Therapy
Child
United States
Infant
Evidence-based Medicine
Autoimmune Diseases / Therapy
Metabolic Diseases / Therapy
Adolescent
Hematopoietic Stem Cell Transplantation
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references

Similar Items